+44 (0) 20 3997 7634 | sales@fbkmed.com

A phase II study of temsirolimus in previously treated advanced hepatocellular carcinoma (HCC).

Home > A phase II study of temsirolimus in previously treated advanced hepatocellular carcinoma (HCC).

A phase II study of temsirolimus in previously treated advanced hepatocellular carcinoma (HCC).

31/05/14

Latest Articles

Appointment of in-country managing director

12/09/23

Bleepa Feedback Medical Feedback PLC

Annual results: Laying the foundations for growth

12/09/23

Bleepa Feedback Medical Feedback PLC

Year end trading update

19/06/23

Bleepa Cadran Feedback Medical Feedback PLC